2026 年的期刊文章 · 第 32 页

共 1756 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2026-02-17 到 2026-02-10。

按期刊、按主题看 →

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 页

JASA Other · 发表于 2026-02-17

Perturbation Analysis of Randomized SVD and its Applications to Statistics

Yichi Zhang, Minh Tang

摘要

Randomized singular value decomposition (RSVD) is a class of computationally efficient algorithms for computing the truncated SVD of large data matrices. Given an m×n matrix M̂, the prototypical RSVD algorithm outputs an approximation of the k leading left singular vectors of M̂ by computing the SVD of M̂(M̂⊤M̂)gG; here g≥1 is an integer and G∈Rn×k˜ is a random Gaussian sketching matrix with k˜≥k. In this paper we derive upper bounds for the l2 and l2,∞ distances between the exact left singular vectors Û of M̂ and its approximation Ûg (obtained via RSVD), as well as entrywise error bounds when M̂ is projected onto ÛgÛg⊤. These bounds depend on the singular values gap and number of power iterations g, and smaller gap requires larger values of g to guarantee the convergences of the l2 and l2,∞ distances. We apply our theoretical results to settings where M̂ is an additive perturbation of some unobserved signal matrix M. In particular, we obtain the nearly-optimal convergence rate and asymptotic normality for RSVD on three inference problems, namely, subspace estimation and community detection in random graphs, noisy matrix completion, and PCA with missing data. *(abstract via OpenAlex)*

SMMR Survival Analysis Causal Inference · 发表于 2026-02-17

Estimating conditional survival benefit for the allocation of scarce resources

Ilaria Prosepe, Nan van Geloven, Hans de Ferrante, Andries E Braat, Hein Putter

摘要

Whenever treatment is scarce, the question of how to allocate resources arises. One option is to allocate based on conditional survival benefit, defined as the contrast between an individual’s expected survival with and without treatment. Estimating conditional survival benefit from observational data may present the following three challenges: (i) time-dependent confounding, arising when treatments are assigned based on longitudinal health markers which are in turn affected by past assignments; (ii) multiple time scales, namely time since becoming eligible for treatment, relevant for comparability of patients, and calendar time, representing when treatment decisions are made; and (iii) multiple versions of treatment, leading to multiple counterfactual outcomes with treatment. Building on previous work where cross-sections and inverse probability of treatment weighting were combined to estimate survival benefit on the treated population, we propose a strategy to dynamically estimate conditional survival benefit for all patients awaiting scarce treatment at any time treatment becomes available, accounting for multiple versions of treatment. After delineating identifiability assumptions, we show in a simulation study that our proposed method improves the estimation of conditional survival benefit compared to simpler methods. The proposed method is then applied to liver transplant data from the Eurotransplant region.

JASA Other · 发表于 2026-02-17

Enhanced Power Enhancements for Testing Many Moment Equalities: Beyond the 2- and ∞-norm

Anders Bredahl Kock, David Preinerstorfer

摘要

Tests based on the 2- and ∞-norm have received considerable attention in high-dimensional testing problems, as they are powerful against dense and sparse alternatives, respectively. The power enhancement principle of Fan et al. (2015) combines these two norms to construct improved tests that are powerful against both types of alternatives. In the context of testing whether a candidate parameter satisfies a large number of moment equalities, we construct tests that harness the strength of all p-norms with p∈[2,∞]. As a result, these tests are consistent against strictly more alternatives than any test based on a single p-norm. In particular, our tests are consistent against more alternatives than tests based on the 2- and ∞-norm, which is what most implementations of the power enhancement principle target.We illustrate our general results in the linear instrumental variable model with many instruments, for which we also provide numerical results and an empirical illustration. *(abstract via OpenAlex)*

JASA Bayesian Methods Meta-Analysis & Data Integration Econometrics & Economics · 发表于 2026-02-17

Covariate-Elaborated Robust Partial Information Transfer with Conditional Spike-and-Slab Prior

Ruqian Zhang, Yijiao Zhang, Juan Shen, Zhongyi Zhu, Annie Qu

摘要

The popularity of transfer learning stems from the fact that it can borrow information from useful auxiliary datasets. Existing statistical transfer learning methods usually adopt a global similarity measure between the source data and the target data, which may lead to inefficiency when only partial information is shared. In this paper, we propose a novel Bayesian transfer learning method named “CONCERT” to allow robust partial information transfer for high-dimensional data analysis. A conditional spike-and-slab prior is introduced in the joint distribution of target and source parameters for information transfer. By incorporating covariate-specific priors, we can characterize partial similarities and integrate source information collaboratively to improve the performance on the target. In contrast to existing work, the CONCERT is a one-step procedure which achieves variable selection and information transfer simultaneously. We establish variable selection consistency, as well as estimation and prediction error bounds for CONCERT. Our theory demonstrates the covariate-specific benefit of transfer learning. To ensure the scalability of the algorithm, we adopt the variational Bayes framework to facilitate implementation. Extensive experiments and two real data applications showcase the validity and advantages of CONCERT over existing cutting-edge transfer learning methods. *(abstract via OpenAlex)*

JASA Bayesian Methods Nonparametric & Semiparametric · 发表于 2026-02-17

Bayesian Nonparametric Spectral Analysis of Locally Stationary Processes

Yifu Tang, Claudia Kirch, Jeong Eun Lee, Renate Meyer

摘要

Stationarity plays a pivotal role in time series analysis. It is not only the basis for the derivation of general asymptotic theory but it also allows an efficient analysis in the frequency domain via the Whittle likelihood, based on the asymptotic independence of the Fourier coefficients. However, many regularly sampled data derived from the observation of physical or ecological processes, for instance, are only locally stationary. They exhibit slowly evolving spectra and asymptotically non-vanishing dependencies between the Fourier coefficients. In this paper we construct a novel dynamic Whittle likelihood approximation for a locally stationary process and propose a Bayesian nonparametric approach to estimate its time-varying spectral density. This dynamic likelihood approximation in the frequency domain can capture the time-frequency evolution of the process by using moving periodograms previously introduced in the bootstrap literature. The posterior distribution is obtained by updating a bivariate extension of the Bernstein-Dirichlet process prior with the dynamic Whittle likelihood. Asymptotic properties such as sup-norm posterior consistency and L2-norm posterior contraction rates are presented. In addition, simulation studies and applications to real-life datasets demonstrate the competitive empirical performance compared to other state-of-the-art methods under finite-sample conditions. *(abstract via OpenAlex)*

JASA Bayesian Methods Nonparametric & Semiparametric · 发表于 2026-02-17

Bayesian Nonparametric Quasi Likelihood

Antonio R. Linero

摘要

A recent trend in Bayesian research has been revisiting generalizations of the likelihood that enable Bayesian inference without requiring the specification of a data generating mechanism. This article focuses on a Bayesian nonparametric extension of Wedderburn’s quasi-likelihood, using Bayesian additive regression trees to model the mean function. Here, the analyst posits only a structural relationship between the mean and variance of the outcome. We show that this approach provides a unified, computationally efficient, framework for extending Bayesian decision tree ensembles to many new settings, including simplex-valued and heavily heteroscedastic data. We also introduce Bayesian strategies for inferring the dispersion parameter of the quasi-likelihood, a task which is complicated by the fact that the quasi-likelihood itself does not contain information about this parameter; despite these challenges, we are able to inject updates for the dispersion parameter into a Markov chain Monte Carlo inference scheme in a way that, in the parametric setting, leads to a Bernstein-von Mises result for the stationary distribution of the resulting Markov chain. We illustrate the utility of our approach on a variety of both synthetic and non-synthetic datasets. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*

JASA Machine Learning · 发表于 2026-02-17

Adversarial Estimation of Riesz Representers

Victor Chernozhukov, Whitney K. Newey, Rahul Singh, Vasilis Syrgkanis

摘要

Many causal parameters are linear functionals of an underlying regression. The Riesz representer is a key component in the asymptotic variance of a semiparametrically estimated linear functional. We propose an adversarial framework to estimate the Riesz representer using general function spaces. We prove a nonasymptotic mean square rate in terms of an abstract quantity called the critical radius, then specialize it for neural networks, random forests, and reproducing kernel Hilbert spaces as leading cases. Our estimators are highly compatible with targeted and debiased machine learning with sample splitting; our guarantees directly verify general conditions for inference that allow mis-specification. We also use our guarantees to prove inference without sample splitting, based on stability or complexity. Our estimators may achieve nominal coverage in highly nonlinear simulations where some previous methods may not. They shed new light on the heterogeneous effects of matching grants. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*

JASA High-Dimensional Latent Variables & Mixtures · 发表于 2026-02-17

A Unified Framework for Estimation of High-Dimensional Conditional Factor Models

Qihui Chen

摘要

This article presents a general framework for estimating high-dimensional conditional latent factor models via constrained nuclear norm regularization. We establish large sample properties of the estimators and provide efficient algorithms for their computation. To improve practical applicability, we propose a cross-validation procedure for selecting the regularization parameter. Our framework unifies the estimation of various conditional factor models, enabling the derivation of new asymptotic results while addressing limitations of existing methods, which are often model-specific or restrictive. Empirical analyses of the cross section of individual US stock returns suggest that imposing homogeneity improves the model’s out-of-sample predictability, with our new method outperforming existing alternatives. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*

JASA Other · 发表于 2026-02-17

A Conditional Ordinal Stereotype Model to Estimate Police Officers’ Propensity to Escalate Force

Greg Ridgeway

摘要

This article introduces a conditional ordinal stereotype model for estimating a police officer’s latent propensity to escalate to higher-severity force options during an encounter. Propensity to escalate is the likelihood of selecting a more serious force category than peer officers confronting the same circumstances, not necessarily implying that such force is excessive or contrary to policy. The associated conditional likelihood depends solely on data from the times and places where multiple officers use various forms of force, precisely the types of situations that police departments are most likely to document. By design, all shared situational and environmental features cancel out of the conditional likelihood, eliminating the need to observe or model them explicitly. The article proves that officer-level inference independent of shared environmental features can arise only from the proposed conditional ordinal stereotype model, establishing it as the unique model with this invariance property. On simulated examples, the conditional ordinal stereotype model recovers which officers escalate force the most, potentially risking unnecessary injuries or fatalities, and which officers may be too reluctant, potentially endangering themselves, colleagues, or the public. Applying the approach to use-of-force data from Seattle finds nine officers with a high probability of being local outliers in their use-of-force networks. By quantifying officer-level variation while accounting for situational context, the conditional ordinal stereotype model expands the analytic toolkit available to police executives and oversight bodies for proactive risk management. *(abstract via OpenAlex)*

SiM Clinical Trials Bayesian Methods · 发表于 2026-02-17

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials

Moka Komaki, Satoru Shinoda, Haiyan Zheng, Kouji Yamamoto

摘要

It is crucial to design Phase II cancer clinical trials that balance the efficiency of treatment selection with clinical practicality. Sargent and Goldberg proposed a frequentist design that allows decision‐making even when the primary endpoint is ambiguous. However, frequentist approaches rely on fixed thresholds and long‐run frequency properties, which can limit flexibility in practical applications. In contrast, the Bayesian decision rule, based on posterior probabilities, enables transparent decision‐making by incorporating prior knowledge and updating beliefs with new data, addressing some of the inherent limitations of frequentist designs. In this study, we propose a novel Bayesian design, allowing the selection of the best‐performing treatment. Specifically, concerning phase II clinical trials with a binary outcome, our decision rule employs posterior interval probability by integrating the joint distribution over all values, for which the 'success rate' of the best‐performing treatment is greater than that of the others. This design can then determine which treatment should proceed to the next phase, given predefined decision thresholds. Furthermore, we propose two sample size determination methods to empower such treatment selection designs implemented in a Bayesian framework. Through simulation studies and real‐data applications, we demonstrate how this approach can overcome challenges related to sample size constraints in randomised trials. In addition, we present a user‐friendly R Shiny application, enabling clinicians to conduct Bayesian designs. Both our methodology and the software application can advance the design and analysis of clinical trials for evaluating cancer treatments.

Biometrika Causal Inference Testing & Uncertainty · 发表于 2026-02-16

Randomization-based confidence sets for the local average treatment effect

P M Aronow, Haoge Chang, Patrick Lopatto

摘要

Summary: We consider the problem of generating confidence sets in randomized experiments with noncompliance. We show that a refinement of a randomization-based procedure proposed by Imbens & Rosenbaum (2005) has desirable properties. Specifically, we show that using a studentized Anderson–Rubin statistic as a test statistic yields confidence sets that are finite-sample exact under treatment effect homogeneity and remain asymptotically valid for the local average treatment effect when the treatment effects are heterogeneous. We provide a uniform analysis of this procedure and efficient algorithms to construct the confidence sets.

Biometrics Genetics & Omics Bayesian Methods Latent Variables & Mixtures · 发表于 2026-02-16

Quantifying uncertainty in RNA velocity

Huizi Zhang, Natalia Bochkina, Sara Wade

摘要

The concept of RNA velocity has made it possible to extract dynamic information from single-cell RNA sequencing data snapshots, attracting considerable attention and inspiring various extensions. Nonetheless, existing approaches often lack uncertainty quantification and many adopt unrealistic assumptions or employ complex black-box models that are difficult to interpret. In this paper, we present a Bayesian hierarchical model to estimate RNA velocity, which uses a time-dependent transcription rate and non-trivial initial conditions. We discuss identifiability of the model parameters, including larger values of the latent time, which has not been done so far. Our approach allows for well-calibrated uncertainty quantification, through a novel algorithm that combines Markov chain Monte Carlo and consensus approaches for full Bayesian inference. The proposed method is validated in a comprehensive simulation study that covers various scenarios, and compared to several other widely embraced and commonly recognized approaches for RNA velocity on single-cell RNA sequencing data from mouse embryonic stem cells. Our method provides estimates of gene-shared latent time and velocity vectors with well-calibrated uncertainty, which align with the cell cycle phases of the cells.

SMMR Survival Analysis Clinical Trials Nonparametric & Semiparametric · 发表于 2026-02-16

Designing clinical trials for the comparison of single and multiple quantiles with right-censored data

Beatriz Farah, Olivier Bouaziz, Aurélien Latouche

摘要

Based on the test for equality of quantiles originally introduced by Kosorok (1999), we propose new power formulas for the comparison of one quantile between two treatment groups, as well as for the comparison of a collection of quantiles. Under the null hypothesis of equality of quantiles, the test statistic follows asymptotically a normal distribution in the univariate case and a χ 2 with J degrees of freedom in the multivariate case, with J the number of quantiles compared. The variance of the test statistic depends on the estimation of the probability density function of the distribution of failure times at the quantile being tested. In order to apply the test on real data, we propose to estimate this quantity using a resampling-based method, as an alternative to Kosorok’s original kernel density estimator. The whole procedure provides a practical tool for designing and analyzing data arising from clinical trials using quantiles of survival as an endpoint. Simulation studies are performed to show the appropriateness of the power formulas. We illustrate the proposed test in a phase III randomized clinical trial where the proportional hazards assumption between treatment arms does not hold.

SiM Causal Inference Nonparametric & Semiparametric · 发表于 2026-02-14,收录于 2026-10-20

Estimating Conditional Complier Quantile Treatment Effect via Stratified Quantile Regression

Huijuan Ma, Mengjiao Peng, Jing Qin

摘要

Understanding the causal effect of a treatment in randomized experiments with noncompliance is of fundamental interest in many domains. Within the instrumental variable (IV) framework, the causal treatment effect can only be reliably assessed for compliers, as they are the only subpopulation whose treatment assignment is influenced by the instrument. In this article, we study the conditional complier quantile treatment effect based on individual characteristics through stratified quantile regression models for compliers with and without treatment, which are flexible in capturing the interaction between treatment and covariates and include the past unified model as a special case. We introduce a tuning parameter-free method that directly utilizes the mixture structure in the compiler problem, departing from past approaches that relied on minimizing a weighted check function with nonparametric method-estimated weights. A novel iterated algorithm is proposed to solve discontinuous equations that involve unknown parameters in a complicated way. The consistency and asymptotic normality of the proposed estimators are established. Numerical results, including extensive simulation studies and real data analysis of the Oregon health insurance experiment and a job training study, show the practical utility of the proposed approach.

SiM Other · 发表于 2026-02-13

Risk‐Adjusted Surgical Learning Curve Assessment Using Comparative Probability Metrics

Adel Ahmadi Nadi, Stefan H. Steiner, Nathaniel T. Stevens

摘要

Surgical learning curves are graphical tools used to evaluate a trainee's progress in the early stages of their career and determine whether they have achieved proficiency after completing a specified number of surgeries. Cumulative sum (CUSUM)–based techniques are commonly used to assess learning curves due to their simplicity, but they face criticism for relying on fixed performance thresholds and lacking interpretability. This paper introduces a risk‐adjusted surgical learning curve assessment (SLCA) method that focuses on estimation rather than hypothesis testing (which is characteristic of CUSUM‐type methods). The proposed method is specifically designed to accommodate right‐skewed outcomes, such as surgery durations, which are well‐characterized by the Weibull distribution. To evaluate the learning process, the proposed SLCA approach sequentially estimates comparative probability metrics that assess the likelihood of a clinically important difference between the trainee's performance and a standard performance. Given the expectation that a trainee's performance will improve over time, we employ a weighted estimating equations approach to the estimation framework to assign greater weight to more recent outcomes compared to earlier ones. Compared to CUSUM‐based methods, the proposed methodology offers enhanced interpretability and deeper insights. It also avoids reliance on externally defined performance levels, which are often difficult to determine in practice, and it emphasizes assessing clinical equivalence or noninferiority rather than simply identifying a lack of difference. The effectiveness of the proposed method is demonstrated through a case study on a colorectal surgery dataset as well as a numerical study.

SiM Latent Variables & Mixtures Longitudinal Data Bayesian Methods · 发表于 2026-02-13

Probabilistic Clustering Using Multivariate Growth Mixture Model in Clinical Settings—A Scleroderma Example

Ji Soo Kim, Yizhen Xu, Rachel S. Wallwork, Laura K. Hummers, Ami A. Shah, Scott L. Zeger

摘要

Background: Scleroderma (systemic sclerosis; SSc) is a chronic autoimmune disease known for wide heterogeneity in patients' disease progression in multiple organ systems. Our goal is to guide clinical care by real‐time classification of patients into clinically interpretable subpopulations based on their baseline characteristics and the temporal patterns of their disease progression. Methods: A Bayesian multivariate growth mixture model was fit to identify subgroups of patients from the Johns Hopkins Scleroderma Center Research Registry who share similar lung function trajectories. We jointly modeled forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO) as pulmonary outcomes for 289 patients with SSc and anti‐topoisomerase 1 antibodies and developed a framework to sequentially update class membership probabilities for any given patient based on her accumulating data. Results: We identified a “stable” group of 150 patients for whom both biomarkers changed little from the date of disease onset over the next 10 years, and a “progressor” group of 139 patients that, on average, experienced a clinically significant decline in both measures starting soon after disease onset. For any given patient at any given time, our algorithm calculates the probability of belonging to the progressor group using both baseline characteristics and the patient's longitudinal FVC and DLCO observations. Conclusions: Our method calculates the probability of being a fast progressor at baseline when no FVC and DLCO are observed, then sequentially updates it as more information becomes available. This sequential integration of patient data and classification of her disease trajectory has the potential to improve clinical decisions and ultimately patient outcomes.

Biometrika Other · 发表于 2026-02-13

Estimating ratios of means of multicategory data observed with sample and category perturbations

David S Clausen, Sarah V Teichman, Amy D Willis

摘要

Summay: We consider the problem of estimating ratios of means of a multivariate outcome across covariates when the data are observed with unknown sample-specific and category-specific perturbations. Our model admits a partially identifiable estimand, and we establish full identifiability by imposing interpretable parameter constraints. To reduce bias and guarantee the existence of estimators in the presence of sparse observations, we apply an asymptotically negligible and constraint-invariant penalty to the loss function. We develop a fast coordinate-descent algorithm for estimation, and an augmented Lagrangian algorithm for estimation under null hypotheses. We construct a model-robust score test and demonstrate valid inference even for small sample sizes and under violated distributional assumptions. The flexibility of the approach, and comparisons with related methods, are illustrated through a simulation study and a meta-analysis of microbial associations with colorectal cancer.

SiM Testing & Uncertainty · 发表于 2026-02-13

Classification‐Specific Predictive Performance: A Unified Estimation and Inference Framework for Multi‐Category Tests

A. Gregory DiRienzo, Elie Massaad, Hutan Ashrafian

摘要

Multi‐cancer testing with localization aims to detect signals from any of a set of targeted cancer types and predict the cancer signal origin from a single biological sample. Such tests have the potential to aid clinical decisions and significantly improve health outcomes. When used for multi‐cancer screening in an asymptomatic population, these tests are referred to as multi‐cancer early detection (MCED) tests. MCED testing has not yet achieved regulatory approval, reimbursement or broad clinical adoption. Some major reasons for this are that the clinical benefits and harms are not well understood, including the risk of unnecessary work‐ups and false reassurance from a negative test that could reduce uptake of standard‐of‐care screening. Part of this uncertainty stems from the use of clinically obtuse metrics to assess the test's clinical validity. Traditionally, performance of MCED tests has been quantified using aggregate measures, disregarding the joint distribution of cancer type, stage (both at intended‐use incidence rates) and predicted cancer signal origin, thereby obscuring biological variability and underlying differences in the test's behavior and limiting insight into true effectiveness. Clinically informative evaluation of an MCED test's performance requires metrics that are specific to cancer type, stage and predicted cancer origin at expected incidence rates in the intended‐use population. In the context of a case–control sampling design, this paper derives analytical methods that allow for unbiased estimation of cancer‐specific intrinsic accuracy, predicted cancer signal origin‐specific predictive value and the marginal test classification distribution, each with corresponding valid confidence interval formulae. A simulation study is presented that evaluates performance of the proposed methodology and provides guidance for implementation. An application to a published MCED test dataset is given. The derived statistical analysis framework in general allows for estimation and inference for pointed metrics of a multi‐category test that enables precisely informed decision‐making, supports optimized trial designs across classical, digital, AI‐driven, and hybrid stratified diagnostic screening platforms, and facilitates informed healthcare decisions by clinicians, policymakers, regulators, scientists, and patients.

JASA Survey & Sampling Econometrics & Economics · 发表于 2026-02-13

Bias Control for M-Quantile-Based Small Area Estimators

Francesco Schirripa Spagnolo, Nicola Salvati, Gaia Bertarelli, David Haziza, Ray Chambers

摘要

Projective outlier-robust M-quantile-based small area estimators can be substantially biased when the sample data contain representative outliers. In this article we propose two new predictive type bias corrected versions of these estimators for continuous and discrete outcomes. Given both area level and individual level outliers in the population, these new estimators are more efficient than the robust-predictive and robust-projective estimators that have been proposed in the small area estimation literature. We also propose two estimators of the prediction mean-squared error of these estimators: one based on Taylor linearization and the other based on a new semi-parametric bootstrap method. We summarize the empirical evidence for these theoretical results in this article, while in the supplementary material we describe in more detail how the properties of these M-quantile-based small area estimators have been assessed in model-based and design-based simulations, as well as in a realistic application focusing on estimation of average income and unemployment rates for local labor market areas in Italy. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*

SiM Longitudinal Data High-Dimensional Survival Analysis · 发表于 2026-02-13

A Functional Joint Model for Survival and Multivariate Sparse Functional Data in Multi‐Cohort Alzheimer's Disease Study

Wenyi Wang, Luo Xiao, Ruonan Li, Sheng Luo, Alzheimer's Disease Neuroimaging Initiative

摘要

We develop an integrative joint model for multivariate sparse functional and survival data to analyze Alzheimer's disease (AD) across multiple studies. To address missing‐by‐design outcomes in multi‐cohort studies, our approach extends the multivariate functional mixed model (MFMM), which integrates longitudinal outcomes to extract shared disease progression trajectories and links these outcomes to time‐to‐event data through a parsimonious survival model. This framework balances flexibility and interpretability by modeling shared progression trajectories while accommodating cohort‐specific mean functions and survival parameters. For efficient estimation, we incorporate penalized splines into an EM algorithm. Application to three AD cohorts demonstrates the model's ability to capture disease trajectories and account for inter‐cohort variability. Simulation studies confirm its robustness and accuracy, highlighting its value in advancing the understanding of AD progression and supporting clinical decision‐making in multi‐cohort settings.

SiM Genetics & Omics · 发表于 2026-02-12

The Generalized Harmonic Mean for p‐Values: Combining Dependent and Independent Tests

Zhengbang Li, Xinjie Zhou

摘要

In medical research, particularly in fields such as genomics, multi‐center clinical trials, and meta‐analysis, effectively combining the p ‐values from multiple related hypothesis tests has always been a challenging statistical issue. To address this problem and enhance the statistical power of comprehensive analysis, this study proposes a generalized harmonic mean for p ‐values (GHMP()) combination method and builds two kinds of combination tests based on this framework. The first kind of test is designed for applications with small significance levels and has more lenient conditions for adapting to correlations, making it suitable for the complex dependency structures commonly found in actual research. The second kind of test introduces a novel high‐order tail approximation technique based on stable distribution theory, which can more accurately estimate the extreme tail probabilities at large significance levels under independent or weakly correlated conditions. Extensive simulation experiments show that both kinds of tests perform robustly across various configurations, with statistical power not inferior to the traditional Cauchy combination test (CCT) and minimum p ‐value (MinP) methods, and demonstrate superior detection capabilities in several scenarios. Additionally, GHMP() has high computational efficiency and has been empirically validated in real genetic data. These characteristics make it a reliable and practical analytical tool for high‐dimensional medical research, such as genome‐wide association studies (GWAS) and large‐scale meta‐analysis.

SiM Clinical Trials · 发表于 2026-02-12

Patient‐Centric Pragmatic Clinical Trials: Opening the DOOR

Scott R. Evans, Qihang Wu, Toshimitsu Hamasaki

摘要

Randomized clinical trials are the gold standard for evaluating the benefits and harms of interventions, though they often fail to provide the necessary evidence to inform medical decision‐making. Primary reasons are failure to recognize the most important questions for informing clinical practice, and that traditional approaches do not directly address these most important questions, and subsequently not using these most important questions as the motivation for the design, monitoring, analysis, and reporting of clinical trials. The standard approach of analyzing one outcome at a time fails to incorporate associations between or the cumulative nature of multiple outcomes in individual patients, suffers from competing risk complexities during interpretation of individual outcomes, fails to recognize important gradations of patient‐centric responses, and since efficacy and safety analyses are often conducted on different populations, benefit:risk estimands and generalizability are unclear. Cardiovascular event prevention trials typically utilize: (1) major adverse cardiovascular events (MACE), for example, stroke, myocardial infarction, and death as the primary endpoint, which fails to recognize multiple events or the differential importance of events, and (2) relative risk models which rely on robustness‐challenging modeling assumptions and are contraindicated in benefit:risk and multiple outcome evaluation. The Desirability Of Outcome Ranking (DOOR) is a paradigm for the design, data monitoring, analysis, interpretation, and reporting of clinical trials based on comprehensive patient‐centric benefit:risk evaluation, developed to address these issues and advance clinical trial science. The rationale and the methodology for the design and analyses for the DOOR paradigm are described. The methods are illustrated using an example. Freely available online tools for the design and analysis of studies implementing the DOOR are provided.

SiM Survival Analysis Causal Inference Machine Learning · 发表于 2026-02-12,收录于 2026-05-01

Neural Network Assisted Estimation for the Structural Nested Accelerated Failure Time Models

Yiming Chen, Tianzhou Ma, Paul Smith, Takumi Saegusa

摘要

Time‐varying confounding complicates the causal survival analysis for longitudinal data. Traditional survival models that adjust for time‐dependent covariates fail to estimate the intervention causal effect unbiasedly. The Structural Nested Accelerated Failure Time Model (SNAFTM) can address this challenge effectively. This model estimates the intervention causal effect as the acceleration factor of the survival time while controlling for the time‐varying confounders. However, the SNAFTM model usually relies on the G‐estimation, which lacks power and suffers from computational burden, especially when the model input data is high‐dimensional with a temporally connected nature. This manuscript presents two Neural Networks based algorithms (GE‐SCORE and GE‐MIMIC) that estimate the SNAFTM. These two algorithms can handle high‐dimensional input data while providing less biased and individualized intervention causal effect estimation, as demonstrated by simulations. The proposed algorithms were also applied to a real observational dataset (CARDIA), and we successfully identified and quantified subjects' smoking causal effects on the time to first cardiovascular events.

SiM Spatial & Time Series Genetics & Omics · 发表于 2026-02-12

Frequency Band Analysis of Multiple Stationary Time Series

Connor K. Brubaker, Jack P. Manning, Jennifer M. Yentes, Scott A. Bruce

摘要

The frequency‐domain properties of biomedical signals offer valuable insights into health and functioning of underlying physiological systems. The power spectrum, which characterizes these properties, is often summarized by partitioning frequencies into standard bands and averaging power within bands. These summary measures are regularly used for analysis in practice, but are not guaranteed to optimally retain differences in power spectra across signals from different participants. We propose a data‐adaptive method for identifying frequency band summary measures that preserve spectral variability within a population of interest. The method can also identify subpopulations with distinct power spectra and summary measures that best characterize local dynamics. Numerical selection criteria are developed to select a reasonable number of bands and subpopulations that best characterize overall dynamics. A genetic algorithm is designed to simultaneously identify subpopulations and their corresponding summary measures. The method is used to analyze stride interval series from patients with different neurological disorders, revealing distinct subpopulations and the need for subpopulation‐dependent summary measures.

SiM Other · 发表于 2026-02-12

A Tutorial on Implementing Statistical Methods for Estimating Excess Death With a Case Study and Simulations on Estimating Excess Death in the Post‐ COVID ‐19 United States

Lillian Rountree, Lauren Zimmermann, Lucy Teed, Daniel M. Weinberger, Bhramar Mukherjee

摘要

Excess death estimation, defined as the difference between the observed and expected death counts, is a popular technique for assessing the overall death toll of a public health crisis. The expected death count is defined as the expected number of deaths in the counterfactual scenario where prevailing conditions continued and the public health crisis did not occur. While excess death is frequently obtained by estimating the expected number of deaths and subtracting it from the observed number, some methods calculate this difference directly, based on historic mortality data and direct predictors of excess deaths. This tutorial provides guidance to researchers on the application of four popular methods for estimating excess death: the World Health Organization's Bayesian model; The Economist's gradient boosting algorithm; Acosta and Irizarry's quasi‐Poisson model; and the Institute for Health Metrics and Evaluation's ensemble model. We begin with explanations of the mathematical formulation of each method and then demonstrate how to code each method in R, applying the code for a case study estimating excess death in the United States for the post‐pandemic period of 2022–2024. An additional simulation study estimating excess death for three different scenarios and three different extrapolation periods further demonstrates general trends in performance across methods; together, these two studies show how the estimates by these methods and their accuracy vary widely depending on the choice of input covariates, reference period, extrapolation period, and tuning parameters. Caution should be exercised when extrapolating for estimating excess death, particularly in cases where the reference period of pre‐event conditions is temporally distant (> 5 years) from the period of interest. In place of committing to one method under one setting, we advocate for using multiple excess death methods in tandem, comparing and synthesizing their results and conducting thorough sensitivity analyses as best practice for estimating excess death for a period of interest. We also call for more detailed simulation studies and benchmark datasets to better understand the accuracy and comparative performance of methods estimating excess death.

SiM Other · 发表于 2026-02-12

A Novel Method for Inserting Dose Levels Mid‐Trial in Early‐Phase Oncology Combination Studies

Matthew George, Ian Wadsworth, Pavel Mozgunov

摘要

The use of combination treatments in early‐phase oncology trials is growing. The objective of these trials is to search for the maximum tolerated dose combination from a predefined set. However, cases in which the initial set of combinations does not contain one close to the target toxicity pose a significant challenge. Currently, solutions are typically ad hoc and may bring practical challenges. We propose a novel method for inserting dose levels mid‐trial, which features a search for the contour partitioning the dose space into combinations with toxicity truly above and below the target toxicity. Establishing this contour with a degree of certainty suggests that no combination is close to the target toxicity, triggering an insertion. We examine our approach in a comprehensive simulation study applied to the PIPE design and two‐dimensional Bayesian logistic regression model (BLRM), though any model‐based or model‐assisted design is an appropriate candidate. Our results demonstrate that, on average, the insertion method can increase the probability of selecting combinations close to the target toxicity, without increasing the probability of subtherapeutic or toxic recommendations.

Biometrics Clinical Trials · 发表于 2026-02-11

Repeated inclusion cluster randomized trials: a new class of designs for assessing group-level interventions

Jessica Kasza, Kelsey L Grantham, Rhys Bowden, Brennan C Kahan, Andrew B Forbes

摘要

Individually randomized trials allow participants to be included in a trial multiple times, with independent randomization at each inclusion. Often referred to as re-randomization designs, these trials have been shown to increase trial recruitment rates. Treatment effect estimators remain unbiased but are more precise than for designs with more participants but no repeat inclusions, but do rely on additional assumptions. Here, we introduce a new class of cluster randomized trial designs: repeated inclusion cluster randomized trials, where some clusters are randomized serially in the same trial. The trial in which clusters are initially included may have a standard cluster randomized design or a longitudinal variant, such as a cluster randomized crossover design. Allowing clusters to participate multiple times in the same trial could reduce the need to recruit new clusters; useful when cluster recruitment is difficult. Assuming a constant treatment effect across repeated inclusions, we show that when equal numbers of clusters and participants are included in each treatment group in each study period, power will be the same or higher as for a similar trial where clusters are not re-randomized but which has the same total number of measurements. Whether power is maintained or increased depends on the study design and the within-cluster correlation structure; increasing the number of within-cluster comparisons increases study power.

SMMR Clinical Trials Nonparametric & Semiparametric Testing & Uncertainty · 发表于 2026-02-11

Rank-based methods for assessing equivalence/non-inferiority with assay sensitivity in a three-arm trial with ordinal endpoints

Shi-Fang Qiu, Dai-Min Li, Wai-Yin Poon

摘要

Various approaches have been developed to assess equivalence/non-inferiority with assay sensitivity in a three-arm trial with continuous or discrete endpoints. However, there is little work done on ordinal endpoints. Ordinal data do not have metric information, the method for analyzing metric endpoints can systematically lead to errors for ordinal observations. The win probability that a subject receiving one treatment achieves a better outcome (or “wins” against) compared to a subject receiving the other treatment, is developed to quantify the treatment effect. In this article, the equivalence/non-inferiority with assay sensitivity in a three-arm trial are assessed by the win probabilities from the perspective of simultaneous confidence intervals (SCIs). The proposed methods can be applied to studies with ordinal or continuous outcomes without making parametric assumptions. Empirical results show that the Fisher-z transformation-based SCI, the method of variance estimates recovery SCIs combing with logit transformation, logit with arcsinh transformation confidence limits perform well in the sense that their empirical coverage probabilities are pretty close to the nominal confidence level. Sample size determination for achieving the pre-specified power is also investigated according to the duality of hypothesis testing and interval estimation. An example taken from the study of prophylaxis of postoperative nausea and vomiting is used to illustrate the proposed methods.

JRSSB Optimization & Learning Theory Nonparametric & Semiparametric · 发表于 2026-02-11,收录于 2026-07-24

Pitman efficiency lower bounds for multivariate distribution-free tests based on optimal transport

Not available

摘要

The Wilcoxon rank sum test is one of the most popular distribution-free two-sample tests for univariate data. Among the important reasons for their popularity are the striking results of Hodges–Lehmann and Chernoff–Savage, where the authors show that the asymptotic (Pitman) relative efficiency of Wilcoxon’s test compared to Student’s t-test, never falls below 0.864 (with identity score) and 1 (with Gaussian score), respectively. Motivated by these results, we propose and study a large family of exactly distribution-free multivariate rank-based two-sample tests by leveraging the theory of optimal transport. First, we propose distribution-free analogues of the Hotelling T2 test and show that they satisfy Hodges–Lehmann and Chernoff–Savage-type efficiency lower bounds over natural sub-families of multivariate distributions—making them the first multivariate, nonparametric, finite-sample distribution-free tests that provably achieve such efficiency lower bounds. Next, we propose exactly distribution-free versions of the celebrated kernel maximum mean discrepancy test. In addition to being distribution-free in finite-samples, these tests are universally consistent under no moment assumptions and have nontrivial Pitman efficiency. To the best of our knowledge, these are the first class of tests to have this trifecta of properties.

Biometrics Spatial & Time Series Clinical Trials · 发表于 2026-02-11

Doubly balanced samples with dynamic sample sizes

Blair Robertson, Chris Price, Marco Reale, Philip Davies

摘要

A spatial sampling design determines where sample locations are placed in a study area to achieve precise estimates of population parameters. Many environmental variables have positive spatial associations, and spatially balanced designs perform well. The recently published dynamic assignment sampling (DAS) design draws spatially balanced master or over-samples in auxiliary spaces. This article proposes a new objective function for DAS to draw doubly balanced master or over-samples, where two balancing properties are satisfied: approximately balanced on auxiliary variables and spatially balanced. All we require is a measure of the distance between population units. Numerical results show that the method generates spatially balanced, balanced, or doubly balanced master or over-samples and compares favorably with established fixed sample size designs. We provide an example application using total aboveground biomass over a large study area in Eastern Amazonia, Brazil, and design-based variance estimators.

SiM Clinical Trials Diagnostics & Prediction Bayesian Methods · 发表于 2026-02-11

Bayesian Sample Size Calculations for External Validation Studies of Risk Prediction Models

Mohsen Sadatsafavi, Paul Gustafson, Solmaz Setayeshgar, Laure Wynants, Richard D Riley

摘要

Contemporary sample size calculations for external validation of risk prediction models require users to specify fixed values of assumed model performance metrics alongside target precision levels (e.g., 95% CI widths). However, due to the finite samples of previous studies, our knowledge of true model performance in the target population is uncertain, and so choosing fixed values represents an incomplete picture. As well, for net benefit (NB) as a measure of clinical utility, the relevance of conventional precision‐based inference is doubtful. In this work, we propose a general Bayesian framework for multi‐criteria sample size considerations for prediction models for binary outcomes. For statistical metrics of performance (e.g., discrimination and calibration), we propose sample size rules that target desired expected precision or desired assurance probability that the precision criteria will be satisfied. For NB, we propose rules based on Optimality Assurance (the probability that the planned study correctly identifies the optimal strategy) and Value of Information (VoI) analysis, which quantifies the expected gain in NB by learning about model performance from a validation study of a given size. We showcase these developments in a case study on the validation of a risk prediction model for deterioration among hospitalized COVID‐19 patients. Compared to conventional sample size calculation methods, a Bayesian approach requires explicit quantification of uncertainty around model performance, and thereby enables flexible sample size rules based on expected precision, assurance probabilities, and VoI. In our case study, calculations based on VoI for NB suggest considerably lower sample sizes are required than when focusing on the precision of calibration metrics. This approach is implemented in the accompanying software.

Biometrics Causal Inference Clinical Trials · 发表于 2026-02-11

A framework for causal estimand selection under positivity violations

Martha Barnard, Jared D Huling, Julian Wolfson

摘要

Estimating the causal effect of a treatment or health policy with observational data can be challenging due to an imbalance of and a lack of overlap between treated and control covariate distributions. In the presence of limited overlap, researchers choose between (1) methods (e.g., inverse probability weighting) that imply traditional estimands but whose estimators are at risk of considerable bias and variance; and (2) methods (e.g., overlap weighting) which imply a different estimand by modifying the target population to reduce variance. We propose a framework for navigating the tradeoffs between variance and bias due to imbalance and a lack of overlap and the targeting of the estimand of scientific interest. We introduce a bias decomposition that encapsulates bias due to (1) the statistical bias of the estimator; and (2) estimand mismatch, i.e., deviation from the population of interest. We propose two design-based metrics and an estimand selection procedure that help illustrate the tradeoffs between these sources of bias and variance of the resulting estimators. Our procedure allows analysts to incorporate their domain-specific preference for preservation of the original research population versus reduction of statistical bias. We demonstrate how to select an estimand based on these preferences with an application to right heart catheterization data.

SiM Clinical Trials · 发表于 2026-02-10

Sample Size Re‐Estimation in Blinded Hybrid‐Control Design Using Inverse Probability Weighting

Masahiro Kojima, Shunichiro Orihara, Keisuke Hanada, Tomohiro Ohigashi

摘要

With the increasing availability of data from historical studies and real‐world data sources, hybrid control designs that incorporate external data into the evaluation of current studies are being increasingly adopted. In these designs, it is necessary to pre‐specify during the planning phase the extent to which information will be borrowed from historical control data. However, if substantial differences in baseline covariate distributions between the current and historical studies are identified at the final analysis, the amount of effective borrowing may be limited, potentially resulting in lower actual power than originally targeted. In this paper, we propose two sample size re‐estimation strategies that can be applied during the course of the blinded current study. Both strategies utilize inverse probability weighting (IPW) based on the probability of assignment to either the current or historical study. When large discrepancies in baseline covariates are detected, the proposed strategies adjust the sample size upward to prevent a loss of statistical power. The performance of the proposed strategies is evaluated through simulation studies, and their practical implementation is demonstrated using a case study based on two actual randomized clinical studies.

SiM Clinical Trials Bayesian Methods · 发表于 2026-02-10

Probability of Success for Establishing Noninferiority Across Multiple Visits: Extension of Covariate‐Adjusted Bayesian Hierarchical Modeling Framework

Yujie Zhao, Yiran Hu, Xiaotian Chen, Jenny Jiao, Qiang Guo, Li Wang

摘要

Effective decision‐making plays a vital role throughout the drug development process, particularly when a proof‐of‐concept (POC) or phase II study has been completed. To determine whether to proceed to a larger‐scale, confirmatory phase III study, assessing the uncertainty about the underlying treatment effect and the probability of success (POS) in the phase III study is of critical importance. In this paper, we proposed and investigated a Bayesian covariate‐adjusted hierarchical modeling approach leveraging historical data with longitudinal outcome to quantitatively assess the POS of the confirmatory phase III trial. Although historical data borrowing methods are widely used and known for the advantages in alleviating recruitment and ethical challenges as well as improving trial operational efficiency, its application to predicting future trial POS with longitudinal outcome over multiple visits pose methodological challenges. This paper not only provided a comprehensive modeling approach but also demonstrated how the proposed model can be used in a Go/No‐Go decision‐making framework with a glaucoma eye care project example. For the approval of new drugs targeting glaucoma, regulatory agencies typically require a pivotal phase III trial to demonstrate noninferiority compared to a standard of care treatment. This may involve meeting both statistical and clinical margins across multiple visits simultaneously. Simulations were performed to evaluate the key factors that affect the operating characteristics, such as between‐trial heterogeneity, subject‐level variance and between‐visit correlation. The proposed decision‐making framework can also be applied to studies in other therapeutical areas with similar settings.

JRSSB High-Dimensional Networks & Graphs Nonparametric & Semiparametric · 发表于 2026-02-10

Penalized empirical likelihood over decentralized networks

Jinye Du, Qihua Wang

摘要

Empirical likelihood encounters serious computational challenges when applied to massive datasets or multiple data sources distributed across decentralized networks. This paper proposes a constrained empirical likelihood framework for decentralized networks, utilizing a novel penalization technique to obtain a penalized empirical log-likelihood. The resulting empirical log-likelihood ratio statistic is proved to be asymptotically standard chi-squared even for a divergent machine number. However, the optimization problem with the fused penalty is still hard to solve in the decentralized distributed network due to the coupling structure. To address the problem, two novel algorithms are developed to solve the optimization problem in a decentralized manner, with established convergence properties and linear convergence for the second algorithm in specific network structures. The methods are validated through simulations and real data analyses of census income and Ford gobike datasets.

JRSSB Spatial & Time Series Nonparametric & Semiparametric · 发表于 2026-02-10

Online kernel CUSUM for change-point detection

Song Wei, Yao Xie

摘要

We present a computationally efficient online kernel Cumulative Sum method for change-point detection that utilizes the maximum over a set of kernel statistics to account for the unknown change-point location. Our approach exhibits increased sensitivity to small changes compared to existing kernel-based change-point detection methods, including the Scan-B statistic, corresponding to a non-parametric Shewhart chart-type procedure. We provide accurate analytic approximations for two key performance metrics: the average run length (ARL) and expected detection delay, which enable us to establish an optimal window length to be on the order of the logarithm of ARL to ensure minimal power loss relative to an oracle procedure with infinite memory. Moreover, we introduce a recursive calculation procedure for detection statistics to ensure constant computational and memory complexity, which is essential for online implementation. Through extensive experiments on both simulated and real data, we demonstrate the competitive performance of our method and validate our theoretical results.

SiM Clinical Trials Longitudinal Data Causal Inference · 发表于 2026-02-10

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials

Hao Wang, Xinyuan Chen, Katherine R. Courtright, Scott D. Halpern, Michael O. Harhay, Monica Taljaard, Fan Li

摘要

In stepped wedge cluster randomized trials (SW‐CRTs), the intervention is rolled out to clusters over multiple periods. A standard approach for analyzing SW‐CRTs utilizes the linear mixed model, where the treatment effect is only present after the treatment adoption, under the assumption of no anticipation. This assumption, however, may not always hold in practice because stakeholders, providers, or individuals who are aware of the treatment adoption timing (especially when blinding is challenging or infeasible) can inadvertently change their behaviors in anticipation of the forthcoming intervention. We provide an analytical framework to address the anticipation effect in SW‐CRTs and study its impact. We derive expectations of the estimators based on a collection of linear mixed models and demonstrate that when the anticipation effect is ignored, these estimators give biased estimates of the treatment effect. We also provide updated sample size formulas that explicitly account for anticipation effects, exposure‐time heterogeneity, or both in SW‐CRTs and illustrate their impact on study power. Through simulation studies and empirical analyses, we compare the treatment effect estimators with and without adjusting for anticipation, and provide some practical considerations.

JRSSB Nonparametric & Semiparametric · 发表于 2026-02-10

Inference on function-valued parameters using a restricted score test

Aaron Hudson, Marco Carone, Ali Shojaie

摘要

It is often of interest to make inference on an unknown function that is a local parameter of the data-generating mechanism, such as a density or regression function. Such estimands can typically only be estimated at a slower-than-parametric rate in nonparametric and semiparametric models, and performing calibrated inference can be challenging. In many cases, these estimands can be expressed as the minimizer of a population risk functional. Here, we propose a general framework that leverages such representation and provides a nonparametric extension of the score test for inference on an infinite-dimensional risk minimizer. We demonstrate that our framework is applicable in a wide variety of problems. As both analytic and computational examples, we describe how to use our general approach for inference on a mean regression function under (i) nonparametric and (ii) partially additive models, and evaluate the operating characteristics of the resulting procedures via simulations. Assessment of effect heterogeneity, inference on density functions, and conditional independence testing are discussed as additional examples.

SiM Clinical Trials · 发表于 2026-02-10

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints

Hyejung Jung, Aya A. Mitani, M. Ishrat Husain, Clement Ma

摘要

Phase 2 clinical trials typically rely on a single primary endpoint, yet in many settings, treatment efficacy must be demonstrated across multiple co‐primary endpoints. Such settings require intersection‐union hypothesis testing, in which the global null hypothesis is rejected only when all individual component hypotheses are rejected. Existing phase 2 designs for binary endpoints are largely restricted to single‐arm or single‐endpoint settings, or rely on large‐sample normal approximations for two‐arm trials, which may be inadequate when sample sizes are small. We developed exact and simulation‐based methods for designing two‐arm, two‐stage phase 2 trials with two co‐primary binary endpoints using the bivariate binomial distribution, allowing different correlations between endpoints across treatment arms. The proposed framework identifies optimal designs that minimize the expected sample size and minimax designs that minimize the maximum sample size, while allowing early termination for futility at the first stage. For small sample sizes (approximately per arm), the exact method is computationally feasible and yields analytically exact operating characteristics under the assumed bivariate binomial distribution. For larger sample sizes, however, exact computations become intensive. To address this, we evaluated a simulation‐based approach and a normal approximation by comparing their performance against the exact method. The simulation approach selected designs that closely matched those from the exact method, whereas the normal approximation often deviated. Therefore, we recommend the simulation‐based method as a computationally efficient and accurate alternative for moderate‐to‐large sample size trials.

SiM Causal Inference High-Dimensional · 发表于 2026-02-10,收录于 2026-10-20

ESPLSM: An Efficient and Interpretable Mediation Analysis Framework Using Sparse Envelopes

Yeonhee Park, Zhihua Su

摘要

Mediation analysis is a fundamental tool for understanding biological mechanisms through which an exposure exerts its effect on an outcome via intermediate variables, or mediators. However, modern biomedical studies often involve multiple exposures and mediators with complex correlation structures, and may also involve multiple outcomes, as in multi-omics or imaging studies, where existing mediation analyses can suffer from instability and limited interpretability. In this work, we propose Envelope-Based Sparse Partial Least Squares for Mediation Analysis (ESPLSM), which integrates dimension reduction and sparsity enforcement via the sparse envelope model to improve estimation and interpretation of causal effects. We embed the envelope model within the causal mediation framework based on potential outcomes, which allows us to formally define and identify direct and indirect effects and to establish theoretical guarantees, including asymptotic efficiency and selection consistency. Through simulation studies, we show that ESPLSM outperforms existing methods in terms of estimation accuracy, statistical power, and variable selection. Finally, we apply ESPLSM to a cancer cell line dataset to investigate the role of RNA expression in mediating the effect of EGFR mutations on drug responses. Our results provide new insights into the molecular mechanisms underlying targeted cancer therapies. Overall, ESPLSM provides a statistically principled yet practical solution for interpretable and efficient mediation analysis in modern high-dimensional biomedical applications.

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 页